Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Fresenius Medical Care AG & Co KGaA ST buy papaver

Start price
€49.24
25.02.14 / 50%
Target price
€52.00
03.04.14
Performance (%)
5.61%
End price
€52.00
03.04.14
Summary
This prediction ended on 03.04.14 with a price of €52.00. With a performance of 5.61%, the BUY prediction by papaver for Fresenius Medical Care AG & Co KGaA ST closed with a slight gain. papaver has 50% into this prediction

Fresenius Medical Care is a leading global provider of dialysis products, services and care, particularly for patients with chronic kidney disease. It operates in over 120 countries and cares for over 345,000 patients worldwide. The company specializes in renal care, manufacturing and distributing products related to dialysis and providing clinical care as well as education and support services for patients with kidney disease. Fresenius Medical Care has been listed on the Frankfurt Stock Exchange since 1996 and on the New York Stock Exchange since 1997. Its symbol, FMCQF, represents its over-the-counter (OTC) stock symbol in the United States.

Performance without dividends (%)
Name 1w 1m 1y 3y
Fresenius Medical Care AG & Co KGaA ST 1.520% 1.520% -10.797% -40.630%
iShares Core DAX® -0.992% -3.231% 11.661% 16.545%
iShares Nasdaq 100 -0.225% -3.339% 36.491% 43.334%
iShares Nikkei 225® -0.736% -7.859% 18.597% 4.253%
iShares S&P 500 -0.509% -2.979% 26.341% 40.911%

Comments by papaver for this prediction

In the thread Fresenius Medical Care AG & Co KGaA ST diskutieren
Prediction Buy
Perf. (%) 5.61%
Target price 52.000
Change
Ends at 03.04.14

FMC höhere Dividende, guter Einstiegskurs

Im letzten Jahr hat FMC mit Kostensenkungen im Gesundheitswesen der USA zu kämpfen. Fakt ist jedoch, dass die Bevölkerung sowohl in Europa, als auch in den USA immer älter werden und immer mehr Menschen deshalb auch dialyseversorgt werden müssen.

Der Vorstandsvorsitzender Rice Powell will die Profitabilität mit einem Sparprogramm steigern. Im laufenden Jahr soll der Umsatz um vier Prozent auf rund 15,2 Milliarden Dollar ansteigen. . Die Dividende für die Aktionäre soll dennoch um zwei Cent auf 0,77 Euro je Aktie steigen - damit hebt FMC seine Ausschüttung zum 17. Mal in Folge an.

 

Gut ist auch, dass diese Aktie auch in stürmischen Zeiten wenig Kursschwankungen zeigt, bei diesem Kurs ist ein Einstieg angesagt.

Deise Aktie gehört zu meinen Alernativen zu Anleihen.

 

Prediction Buy
Perf. (%) 5.61%
Target price 52.000
Change
Ends at 03.04.14

(Zielkurs erreicht)

Stopped prediction by papaver for Fresenius Medical Care AG & Co KGaA ST

buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€74.78
07.05.19
€76.00
12.05.20
-1.55%
12.05.20

buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€69.04
31.10.18
€80.10
30.04.19
8.02%
30.04.19

buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€79.57
17.08.17
€82.00
18.09.17
3.08%
18.09.17

buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€75.63
23.01.17
€81.00
08.03.17
3.32%
08.03.17

buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€73.69
31.10.16
€81.00
20.12.16
8.70%
20.12.16

buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€49.75
02.07.13
€55.00
17.01.14
6.58%
17.01.14

buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€51.80
06.06.13
€55.00
27.06.13
6.18%
27.06.13

buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€56.96
29.10.12
€60.10
06.06.13
-6.72%
06.06.13

buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€54.80
08.02.12
€57.50
11.07.12
6.19%
11.07.12

buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€50.01
31.05.11
€55.00
30.11.11
-0.92%
30.11.11